AEHR vs FFIV
Aehr Test Systems vs F5, Inc. — AI-powered side-by-side comparison
AEHR
Aehr Test Systems
54
Watch
VS
| Metric | AEHR | FFIV |
|---|
| AI Score |
54
|
69
|
| Price |
$117.30
|
$413.92
|
| P/E Ratio |
-509.48×
|
32.60×
|
| ROE |
-3.2%
|
19.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
34.7%
|
82.2%
|
| Debt / Equity |
0.04×
|
0.06×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
72.5
|
54.1
|
| Beta |
3.087
|
1.033
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for AEHR versus FFIV.
FFIV leads by 15 points.
FFIV scores 69/100 (Buy) versus AEHR at 54/100 (Watch).
AEHR Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -26.4% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -8.9% -- cheap may mean cheap for a reason — Value
- Revenue declining -26.4% YoY -- this is not a growth story right now — Growth
- RSI at 72 is in overbought territory — Technical
FFIV Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is p/e of 31.6 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 19.9% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 31.6 is moderate-to-rich — Value
- Price-to-book of 5.2x prices in significant intangible value — Value